WEB RELEASE

Frost and Sullivan spotlights Calgary Scientific in post-RSNA report

Accessibility named key factor for advanced visualization companies

Calgary, AB – February 13, 2009 - Calgary Scientific Inc., a leading innovator in advanced visualization solutions, was recently featured in Frost and Sullivan’s Vital Signs in a post-RSNA (Radiological Society of North America) report on medical imaging. Frost and Sullivan is the leading global provider of actionable market, technical and econometric research across the medical IT industry. The report examines trends spotted at the most recent RSNA annual meeting. Vital Signs identifies accessibility as a major requirement that advanced visualization companies must fulfill to be successful in the current and future medical IT marketplace. The report chose Calgary Scientific Inc., the PureWeb™ platform, and the ResMD™ product line of powerful advanced visualization tools and sophisticated cardiac and vascular clinical modules for its company spotlight.

“The medical industry is quickly realizing the significant advantage that Calgary Scientific can offer through the PureWeb™ delivery of our ResMD advanced visualization products as well as enabling third-party applications from across the industry,” states Byron Osing, CEO and Chair at Calgary Scientific. “The Frost and Sullivan report highlights user access which fully aligns with our PureWeb strategy and true industry-wide virtualization. Flexible web access to multiple applications for radiologists and other medical practitioners will rapidly lead to improved efficiencies, reduced costs, enhanced communication and ultimately, better patient care. For medical software and technology vendors, PureWeb opens up opportunities for new revenue, rapid product-line diversification, enterprise platform unification and lower cost of goods sold. This capability promises increased customer retention and new account penetration as the movement to virtual technologies will be required to be competitive today and in the future. We are pleased to have been spotlighted by Frost and Sullivan as a company addressing the needs of the market.”

The report is available to Frost and Sullivan subscribers and can be accessed at:

http://www.frost.com/prod/servlet/market-service-segment.pag?segid=9561-00-80-00-00.

About Frost and Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

About Calgary Scientific Inc.

Calgary Scientific is dedicated to providing advanced visualization solutions for medical imaging that improves the efficiency and quality of diagnosis made by imaging professionals. Calgary Scientific has a powerful portfolio of products that perform sophisticated image post-processing, including tools for 2D, MIP/MPR and 3D, a suite of cardiac modules for both CT and MR, and vessel analysis. Calgary Scientific also has proprietary intellectual property for image fusion, virtual colonoscopy and Computer Assisted Tissue Identification (CATI™). Calgary Scientific aims to be the premier provider of advanced visualization solutions in the medical imaging market. For more information on Calgary Scientific, go to www.calgaryscientific.com.

© 2009 Calgary Scientific Inc., ResMD, CATI and the Calgary Scientific logo are trademarks of Calgary Scientific. All other third-party company names and products are for identification purposes only and may be trademarks of their respective owners.

Press Contact:

Jenn Poole

Calgary Scientific

Marketing Communications

Jenn.Poole@calgaryscientific.com

(+1) 403.921.0278

Investor contact:

Byron Osing

Calgary Scientific

CEO and Chair

Byron.Osing@calgaryscientific.com

(+1) 403.270.7159 ext 959 

Return to Calgary Scientific Inc. Homepage